X
Last BACE bombs: Eisai, Biogen give up on elenbecestat
https://pharmaphorum.com/news/last-bace-bombs-eisai-biogen-give-up-on-elenbecestat/
BACE inhibitors
Merck’s failure casts gloom over remaining BACE Alzheimer’s drugs
But trial in patients in early stage of the disease continues.